These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7745806)

  • 1. [Reevaluation of current antimicrobials. Ciprofloxacin. Discussion].
    Jpn J Antibiot; 1995 Feb; 48(2):175-82. PubMed ID: 7745806
    [No Abstract]   [Full Text] [Related]  

  • 2. Ciprofloxacin for the treatment of osteomyelitis: a review.
    Hessen MT; Levison ME
    J Foot Surg; 1989; 28(2):100-5. PubMed ID: 2661635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibacterial effectiveness of ciprofloxacin].
    Sziegoleit A
    Fortschr Med; 1986 Sep; 104(33):610-2. PubMed ID: 3770634
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effective microbiologic spectrum of gyrase inhibitors--indications and contraindications].
    Tauchnitz C
    Z Gesamte Inn Med; 1990 Sep; 45(17):509-12. PubMed ID: 1963246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norfloxacin, ciprofloxacin, and ofloxacin: current clinical roles.
    Hooper DC; Wolfson JS
    Curr Clin Top Infect Dis; 1989; 10():194-240. PubMed ID: 2679694
    [No Abstract]   [Full Text] [Related]  

  • 6. Ciprofloxacin: a major advance in quinolone chemotherapy.
    Am J Med; 1987 Apr; 82(4A):1-404. PubMed ID: 3578318
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ciprofloxacin in the treatment of infections in oncology patients].
    Dronova OM
    Antibiot Khimioter; 1990 Nov; 35(11):51-4. PubMed ID: 2092640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of ciprofloxacin per os in treatment of serious infections.
    Dellamonica P; Bernard E; Etesse H; Garraffo R; Beziau H
    Chemioterapia; 1987 Jun; 6(2 Suppl):391-4. PubMed ID: 3509456
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reevaluation of current antimicrobials. Cefpodoxime proxetil. Discussion].
    Jpn J Antibiot; 1995 Feb; 48(2):183-90. PubMed ID: 7745807
    [No Abstract]   [Full Text] [Related]  

  • 10. [New specifics registered in Austria].
    Wien Klin Wochenschr; 1987 Sep; 99(18):655-63. PubMed ID: 3687025
    [No Abstract]   [Full Text] [Related]  

  • 11. Ciprofloxacin versus placebo in the treatment of acute bacterial diarrhea.
    Pichler H; Diridl G; Stickler K; Wolf D
    Chemioterapia; 1987 Jun; 6(2 Suppl):490-1. PubMed ID: 3334608
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reevaluation of current antimicrobials. cefdinir (discussion)].
    Jpn J Antibiot; 1995 Jun; 48(6):733-40. PubMed ID: 7666577
    [No Abstract]   [Full Text] [Related]  

  • 13. [[New antimicrobial agent series XXXII]: ciprofloxacin].
    Kobayashi H
    Jpn J Antibiot; 1988 Nov; 41(11):1563-77. PubMed ID: 3062203
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reevaluation of current antimicrobials. Series 15: aztreonam. Discussion].
    Jpn J Antibiot; 1994 Sep; 47(9):1123-30. PubMed ID: 7990254
    [No Abstract]   [Full Text] [Related]  

  • 15. Microbial resistance to ciprofloxacin.
    Tullio CJ
    Am J Hosp Pharm; 1992 Jan; 49(1):73. PubMed ID: 1570869
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fluoroquinolones--a new and important group of antimicrobial agents].
    Sander J
    Tidsskr Nor Laegeforen; 1992 Jan; 112(3):346-9. PubMed ID: 1553674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reevaluation of current antimicrobials: cefodizime. Discussion].
    Matsumoto K; Nagayama A
    Jpn J Antibiot; 1995 Mar; 48(3):303-10. PubMed ID: 7752447
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ciprofloxacin in bacterial infections].
    Belovezhdov N; Monova D
    Vutr Boles; 1989; 28(5):20-4. PubMed ID: 2618005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Where are we now with ciprofloxacin?
    Hawkey PM
    J Antimicrob Chemother; 1989 Oct; 24(4):477-80. PubMed ID: 2693428
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reevaluation of current antimicrobials. Series 14: sulbactam sodium/cefoperazone sodium. Discussion].
    Jpn J Antibiot; 1994 Sep; 47(9):1115-22. PubMed ID: 7990253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.